Asthma and Corneal opacity

Summary:

Corneal opacity is found among people with Asthma, especially for people who are female, 60+ old.

The study analyzes which people have Corneal opacity with Asthma. It is created by eHealthMe based on reports of 15 people who have Asthma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Asthma?

Asthma is found to be associated with 2,097 drugs and 2,614 conditions by eHealthMe. Check the latest studies of Asthma.

What is Corneal opacity?

Corneal opacity (scarring or clouding of the cornea) is found to be associated with 125 drugs and 316 conditions by eHealthMe. Check the latest studies of Corneal opacity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

15 people who have Asthma and Corneal Opacity are studied.

Would you have Corneal opacity when you have Asthma?

Gender of people who have Asthma and experienced Corneal Opacity *:

  • female: 73.33 %
  • male: 26.67 %

Age of people who have Asthma and experienced Corneal Opacity *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 21.43 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 7.14 %
  • 50-59: 7.14 %
  • 60+: 64.29 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 8 people, 53.33%
  2. Keratoconus (a condition in which your eye's cornea is unable to hold its round shape): 3 people, 20.00%
  3. High Blood Cholesterol: 3 people, 20.00%
  4. Stress And Anxiety: 2 people, 13.33%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 13.33%
  6. Psoriasis (immune-mediated disease that affects the skin): 2 people, 13.33%
  7. Pain: 2 people, 13.33%
  8. Injury Corneal: 2 people, 13.33%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%
  10. Dry Mouth: 2 people, 13.33%

Common drugs taken by these people *:

  1. Amlodipine: 6 people, 40.00%
  2. Xolair: 6 people, 40.00%
  3. Theo-Dur: 5 people, 33.33%
  4. Ventolin: 3 people, 20.00%
  5. Humira: 3 people, 20.00%
  6. Proair Hfa: 3 people, 20.00%
  7. Lidoderm: 2 people, 13.33%
  8. Photrexa: 2 people, 13.33%
  9. Vitamin D3: 2 people, 13.33%
  10. Neurontin: 2 people, 13.33%

Common symptoms for these people *:

  1. Wheezing (a high-pitched whistling sound made while you breath): 6 people, 40.00%
  2. Hip Fracture: 6 people, 40.00%
  3. Weight Increased: 6 people, 40.00%
  4. Joint Injury: 6 people, 40.00%
  5. Lower Respiratory Tract Infection: 6 people, 40.00%
  6. Fall: 6 people, 40.00%
  7. Malaise (a feeling of general discomfort or uneasiness): 6 people, 40.00%
  8. Muscle Aches (muscle pain): 6 people, 40.00%
  9. Dysstasia (difficulty in standing): 6 people, 40.00%
  10. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 6 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Corneal opacity?

- Check whether Corneal opacity is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Corneal opacity:

All the conditions that are associated with Corneal opacity:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Corneal opacity and Asthma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: